Online CME

2021

Saving the Hearts of Women Through Prevention (September 22, 2021 - September 21, 2022)

Reducing Cardiovascular Risk in Men Receiving Androgen Deprivation Therapy

Protecting Our Patients From ASCVD: Optimizing the Use of Non-Statin Therapies (October 29, 2021 - October 29, 2022)

Homozygous Familial Hypercholesterolemia: A Call to Action to Improve Diagnosis and Management

ASPC 2021 OnDemand Preventive Cardiology Experts Course (November 1, 2021 - February 1, 2022)

ASPC 2021 OnDemand Virtual Summit on CVD Prevention (August 6, 2021 - February 6, 2022)

2020

CME Program - Reducing Mortality and Hospitalization in Heart Failure: Research Updates and Novel Treatments for HFpEF and HFrEF (October 20, 2020 from 3:00-4:00 PM EST)

CME Program - Heart Failure: Exploring Gender Differences in its Presentation and Management (October 20, 2020 - 2:00-3:00 PM EST)

Reducing Risk of MI and Stroke in Patients With Established CVD: Role of PCSK9 Inhibitors - CME Program

Dyslipidemia, Diabetes, And Cardiovascular Risk: Clinical Strategies and Evolving Treatments - CME program

Primary CV Risk Reduction Strategies - CME Program

T2D Management: Focus on CV Event Prevention - CME Program

2019

Diabetes from the Perspective of the Cardiologist: An Evolving Paradigm - CME Program

Shared-Decision Making in Dyslipidemia: What Do the Latest Cholesterol Guidelines Suggest? - CME Program

2018

Addressing Access to PCSK9 Inhibitors: Tips and Tools for Practicing Clinicians - CME Program